{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-075201","form_type":"8-K/A","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2024-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.815011+00:00","generated_at":"2026-06-01T01:54:13.501024+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Century Therapeutics files financials of acquired Clade; Clade had $38.6M net loss in 2023","bullets":["Clade's audited FY2023 net loss $38.6M, accumulated deficit $51.8M as of Dec 31, 2023.","Clade had $14.2M cash at year-end 2023; going concern doubt noted for next 12 months.","Unaudited pro forma combined financials for FY2023 filed; acquisition closed April 11, 2024.","No deal value disclosed in this amendment; prior 8-K on April 11 announced acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-075201","json":"https://secwatch.observer/filing/0001104659-24-075201.json","markdown":"https://secwatch.observer/filing/0001104659-24-075201.md","text":"https://secwatch.observer/filing/0001104659-24-075201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465924075201/0001104659-24-075201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465924075201/tm2418216d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:54:13.501024+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}